MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1158.87%
Quick Ratio
1158.87%
Cash Ratio
222.19%
Debt to Asset Ratio
8.49%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Other assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable-Nonrelated Part...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
96,599
323,462
96,685
171,673
Prepaid expenses and other assets
6,561
5,162
7,252
7,205
Marketable securities
400,660
216,291
318,116
118,494
Total current assets
503,820
544,915
422,053
297,372
Property and equipment, net
362
346
330
135
Right of use asset operating lease
1,151
1,428
1,701
1,969
Long term investments
-
-
-
117,417
Other assets
6,910
6,910
6,910
7,795
Total assets
512,243
553,599
430,994
424,688
Accounts payable-Nonrelated Party
7,431
6,188
5,515
3,003
Accounts payable-Related Party
1,032
1,252
2,278
659
Accrued expenses and other current liabilities-Nonrelated Party
33,666
29,948
18,898
14,986
Accrued expenses and other current liabilities-Related Party
183
812
1,141
1,285
Operating lease liability current portion
1,163
1,140
1,117
1,095
Total current liabilities
43,475
39,340
28,949
21,028
Operating lease liability net of current portion
0
301
593
880
Total liabilities
43,475
39,641
29,542
21,908
Common stock, 0.0001 par value, 500,000,000 shares authorized 65,931,128 and 56,600,724 shares issued and outstanding as of june30, 2026 and december31, 2025, respectively
8
8
7
7
Additional paid-in capital
939,940
929,370
760,168
724,489
Accumulated other comprehensive (loss) income
-567
-243
243
-136
Accumulated deficit
-470,613
-415,177
-358,966
-321,580
Total stockholders' equity
468,768
513,958
401,452
402,780
Total liabilities and stockholders equity
512,243
553,599
430,994
424,688
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$400,660K Cash and cashequivalents$96,599K (-77.88%↓ Y/Y)Prepaid expenses andother assets$6,561K (-15.72%↓ Y/Y)Total current assets$503,820K (13.37%↑ Y/Y)Other assets$6,910K (0.99%↑ Y/Y)Right of use asset operating lease$1,151K (-48.55%↓ Y/Y)Property and equipment,net$362K (209.40%↑ Y/Y)Total assets$512,243K (12.93%↑ Y/Y)Total liabilities andstockholders equity$512,243K (12.93%↑ Y/Y)Total stockholders'equity$468,768K (7.71%↑ Y/Y)Total liabilities$43,475K (136.39%↑ Y/Y)Accumulated deficit-$470,613K (-64.98%↓ Y/Y)Accumulated othercomprehensive (loss) income-$567K Additional paid-in capital$939,940K (30.47%↑ Y/Y)Total currentliabilities$43,475K (152.37%↑ Y/Y)Common stock, 0.0001par value,...$8K (14.29%↑ Y/Y)Accrued expenses andother current...$33,666K (180.55%↑ Y/Y)Accountspayable-Nonrelated Party$7,431K (264.09%↑ Y/Y)Operating lease liability current portion$1,163K (8.29%↑ Y/Y)Accountspayable-Related Party$1,032K (18.62%↑ Y/Y)Accrued expenses andother current...$183K (-85.27%↓ Y/Y)

Bicara Therapeutics Inc. (BCAX)

Bicara Therapeutics Inc. (BCAX)